Gender imbalances induced by age limits in stroke trials

Neuroepidemiology

Volumn 35, Issue 3, 2010, Pages 226-230

  Foerch, Christian ^a   Czapowski, Dirk ^b   Misselwitz, Bjoern ^c   Steinmetz, Helmuth ^a   Neumann Haefelin, Tobias ^a  

^a GOETHE UNIVERSITY   (Germany)

^b KRANKENHAUS NORDWEST   (Germany)

^c Geschaftsstelle Qualitatssicherung Hessen   (Germany)

Author keywords

Age; Clinical trials; Gender; Ischaemic stroke

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL PRACTICE; DISEASE REGISTRY; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE PAYMENT; SEX DIFFERENCE; SEX RATIO;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; FEMALE; GERMANY; HUMANS; LIFE EXPECTANCY; MALE; PATIENT SELECTION; PROSPECTIVE STUDIES; REGISTRIES; SEX DISTRIBUTION; STROKE;

EID: 77956811935     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319457     Document Type: Article

References (25)

1. Eurostat: Europe in Figures - Eurostat Statistical Yearbook 2008. Luxemburg, Eurostat, 2008.
2. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, Katalinic A, Lang E, Gassmann KG, von Stockert TR: A prospective communitybased study of stroke in Germany - the Erlangen stroke project (ESPRO): incidence and case fatality at 1, 3, and 12 months. Stroke 1998; 29: 2501-2506.
3. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM, Farmer A, Sandercock PA, Dennis MS, Warlow CP, Bamford JM, Anslow P: Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK, from 1981 to 2004 (Oxford vascular study). Lancet 2004; 363: 1925-1933.
4. McMurdo ME, Witham MD, Gillespie ND: Including older people in clinical research. BMJ 2005; 331: 1036-1037.
5. Witham MD, McMurdo ME: How to get older people included in clinical studies. Drugs Aging 2007; 24: 187-196.
6. Actilyse Gebrauchsinformation. Ingelheim, Boehringer Ingelheim, 2007.
7. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ: Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 2007; 38: 2612-2618.
8. Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T: Difference in recognition of right and left hemispheric stroke. Lancet 2005; 366: 392-393.
9. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH): E7 studies in support of special populations: geriatrics. Geneva, ICH Secretariat www.ich. org.
10. Elkind MS, Prabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC: Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology 2007; 68: 842-848.
11. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP: Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005; 36: 62-65. (Pubitemid 40054176)
12. Saposnik G, Di Legge S, Webster F, Hachinski V: Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005; 65: 1169-1174.
13. Savitz SI, Schlaug G, Caplan L, Selim M: Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005; 36: 1447-1451.
14. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL: Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta- analysis of randomized controlled trials. JAMA 2006; 295: 306-313.
15. Williams JE, Chimowitz MI, Cotsonis GA, Lynn MJ, Waddy SP: Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke 2007; 38: 2055-2062.
16. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S: Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-2026.
17. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
18. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P; Second European-Australasian Acute Stroke Study Investigators: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-1251.
19. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D: Thrombolysis with alteplase 3-4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
20. National Institute of Neurological Disorders and Stroke rt-PA stroke study group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
21. Grond M, Stenzel C, Schmulling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD: Early intravenous thrombolysis for acute ischemic stroke in a communitybased approach. Stroke 1998; 29: 1544-1549.
22. Engelter ST, Bonati LH, Lyrer PA: Intravenous thrombolysis in stroke patients of 6 80 versus ! 80 years of age - a systematic review across cohort studies. Age Ageing 2006; 35: 572-580.
23. Khaw KT, Barrett-Connor E, Suarez L, Criqui MH: Predictors of stroke-associated mortality in the elderly. Stroke 1984; 15: 244-248.
24. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P: The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials 2008; 9: 37.
25. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L: Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008; 7: 915-926.